Loading Events

Major Depressive Disorder In Chronic Kidney Disease

A joint virtual live event for NephU & PsychU members.

In this virtual live event, Shirin Sundar, PhD and Becky Wong, PharmD, MBA, discuss the high prevalence of major depressive disorder (MDD) among patients with chronic kidney disease (CKD) and end-stage renal disease (ESRD).

Major depressive disorder affects more than 260 million people worldwide1. The reported prevalence of depression in patients with chronic kidney disease ranges from 20-65%2. This webinar provides an overview of both MDD and CKD and discusses their overlap of symptomology.

1World Health Organization. Fact Sheet on Depression. (2012)
2Teles F et al. Clinics (Sao Paulo). 2014 ;69(3):198-202.

*Speakers are employees of Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC).

You must be logged in to register for this event.

If you would like to register for the 3:00 pm to 4:00 pm EST broadcast, please click below:

Featured Speakers
Shirin Sundar

Shirin Sundar, PhD

Nephrology Senior Medical Science Liaison
    Otsuka Pharmaceutical Development & Commercialization, Inc.*

Shirin Sundar, PhD is a Senior Medical Science Liaison at Otsuka, based out of the San Francisco bay area. Dr Sundar earned her Master’s and PhD in Cell and Molecular Biology from Birla Institute of Technology and Science, Pilani, India and the Uniformed Services University, Bethesda, Maryland. She did her post-doctoral training at the Kidney Institute, University of Kansas on elucidating the molecular mechanisms of polycystic kidney disease (PKD), and preclinical drug development for PKD. Prior to joining Otsuka, Dr Sundar held an Assoc. Specialist Scientist position at the University of California San Francisco.

Dr Sundar has presented several abstracts and published peer-reviewed manuscripts in the areas of cellular oxidative stress, innate immune pathways, polycystic kidney disease, and hyponatremia outcomes research.

Becky Wong

Becky Wong, PharmD, MBA

Senior Medical Science Liaison
    Otsuka Pharmaceutical Development & Commercialization, Inc.*

Areas of Expertise:

  • Psychiatry
  • Community / Clinical Pharmacy
  • Health Care Management
  • Medication Therapy Management
  • Managed Care